MAFG-driven osteosarcoma cell progression is inhibited by a novel miRNA miR-4660.
Ontology highlight
ABSTRACT: Osteosarcoma (OS) is the most common primary bone malignancy in the adolescent population. MAFG (v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G) forms a heterodimer with Nrf2 (NF-E2-related factor 2), binding to antioxidant response element (ARE), which is required for Nrf2 signaling activation. We found that MAFG mRNA and protein expression is significantly elevated in human OS tissues as well as in established and primary human OS cells. In human OS cells, MAGF silencing or knockout (KO) largely inhibited OS cell growth, proliferation, and migration, simultaneously inducing oxidative injury and apoptosis activation. Conversely, ectopic overexpression of MAFG augmented OS cell progression in vitro. MicroRNA-4660 (miR-4660) directly binds the 3' untranslated r
SUBMITTER: Shan HJ
PROVIDER: S-EPMC8039776 | biostudies-literature | 2021 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA